Patents
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
06/2000
06/08/2000WO2000032600A1 8-azabicyclo[3.2.1]oct-2-ene and -octane derivatives
06/08/2000WO2000032253A1 Radiopaque implantable collagenous biomaterial device
06/08/2000WO2000032250A1 A multi-formed collagenous biomaterial medical device
06/08/2000WO2000032240A2 Radioconjugation of internalizing antibodies
06/08/2000WO2000012536A3 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides
06/08/2000DE19855786A1 Expandable stent, especially useful for preventing restenosis of coronary arteries, is implanted with carbon to improve hemocompatibility and provided with a radioactive material to inhibit restenosis
06/08/2000CA2342621A1 8-azabicyclo[3.2.1]oct-2-ene and -octane derivatives
06/07/2000EP1005870A2 Therapeutic application of chimeric antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
06/07/2000EP1005494A1 High avidity polyvalent and polyspecific reagents
06/07/2000EP1005356A1 Novel antibacterial agents
06/07/2000EP1005335A1 Process for preparing a reactive pharmaceutical product for the detection of gastrointestinal disorder caused by bacteria in the gastrointestinal superior tract
06/07/2000CN1255860A Immunogenic compsns to CCK-b/gastrin-receptor and methods for treatment of tumors
06/06/2000US6072038 Conjugates of texaphyrins
06/06/2000US6071925 Antidepressants, anticonvulsants or antianxiety agents, also for treatment of memory loss in alzheimer's disease
06/06/2000US6071723 Inhibitors of human plasmin derived from the Kunitz domains
06/06/2000US6071705 Method of detecting neurological disease or dysfunction
06/06/2000US6071515 Dimer and multimer forms of single chain polypeptides
06/06/2000US6071493 Method of screening for an agent that inhibits mononuclear phagocyte-plaque component complex formation
06/06/2000US6071492 Cardiac tropism radiopharmaceutical products incorporating a nitride complex of a transition metal and having a rapid myocardial clearance
06/06/2000US6071491 Administering an antibody against cell ghosts, wherein the antibody is specific to an intracellular antigen not present on the cell surface of normal or neoplastic cells, and wherein the antibody is labeled
06/06/2000US6071490 Administering a bi-specific antibody and subsequently administering a chelate-ga-68 complex
06/06/2000US6071245 Diagnostic agent for liver function
06/02/2000WO2000031122A1 Hydrophilic somatostatin analogs
06/02/2000WO1999061097A9 Alpha emitting constructs and uses thereof
06/02/2000CA2351944A1 Hydrophilic somatostatin analogs
05/2000
05/31/2000EP1004322A2 Technetium-99m labeled peptides for thrombus imaging
05/31/2000EP1004321A1 Stable radioactive medecine
05/31/2000EP1003729A1 6-azauracil derivatives as il-5 inhibitors
05/31/2000EP1003560A1 Radioprotectant for peptides labeled with radioisotope
05/31/2000EP1003541A1 Inhibitors of hiv reverse transcriptase
05/30/2000US6069140 Pharmaceutical compositions comprising texaphyrins
05/30/2000US6069134 Methods and compositions comprising DNA damaging agents and p53
05/30/2000US6068984 Separating hb15 prositive cells from population of unrelated cells by reacting antibody that specifically binds the extracellular, transmembrane or cytoplasmic domain of the glycoprotein, then isolating cells
05/30/2000US6068830 In vivo method for imaging breast and ovarian cancers in non-prostatic tissue of a patient
05/25/2000WO2000029501A1 Radioactive coating solutions, methods, and substrates
05/25/2000WO2000029035A1 X-ray emitting surgical device
05/25/2000WO2000029034A1 Products and methods
05/24/2000EP1002548A2 Process for determining effects of external stimuli on the brain using positron emission tomography
05/24/2000EP1002506A1 Radioactive stent
05/24/2000EP1001984A1 NOVEL ESTROGEN RECEPTOR $g(b) AND ISOFORMS
05/24/2000EP1001983A1 NOVEL ESTROGEN $g(b) RECEPTOR AND ISOFORMS
05/24/2000EP1001977A2 Radiolabeled peptides for the diagnosis and treatment of breast and prostate tumors and metastases of such tumors
05/24/2000EP0794788A4 Hepatic-directed compounds and reagents for preparation thereof
05/24/2000EP0529031B1 Improved inhibitors of thrombin
05/24/2000CN1254375A Motilin homologs
05/24/2000CN1254346A Calcitonin receptor-binding peptides
05/24/2000CN1254295A Stents with radioactive surface coating, its preparing method and use for preventing renarrow
05/23/2000US6066319 Administering membrane attack complex (mac) transmembrane channel forming agent which is an antibody simultaneously therewith an effective amount of a therapeutic or diagnostic agent
05/23/2000US6066310 Diagnostic and therapeutic method for tumor using radiolabeled avidin
05/23/2000US6066309 Post-labeling stabilization of radiolabeled proteins and peptides
05/18/2000WO2000028554A1 Products and methods for brachytherapy
05/18/2000DE19853067A1 Radioaktiver Stent Radioactive stent
05/18/2000CA2345620A1 Products and methods for brachytherapy
05/17/2000EP1000082A2 Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
05/17/2000EP1000040A1 Il-5 inhibiting 6-azauracil derivatives
05/17/2000EP0999856A2 Radiopharmaceuticals for imaging infection and inflammation
05/17/2000EP0999782A1 A breath test for the diagnosis of bacterial infection
05/17/2000CA2283516A1 Radioactive stent
05/16/2000CA2131826C Mn gene and protein
05/16/2000CA2081637C Rhenium and technetium complexes containing a hypoxia-localizing moiety
05/16/2000CA2063551C Method for preparing radiodiagnostic gaseous radionuclide and apparatus
05/11/2000WO2000026394A1 Variants of humanized anti-carcinoma monoclonal antibody cc49
05/11/2000WO2000025841A1 Implant with cavities containing therapeutic agents
05/11/2000WO2000025829A2 Radiodense compositions
05/11/2000WO2000025819A1 Enhanced radiation therapy
05/11/2000WO2000009076A3 Imaging with tc-99m labeled fibrin-alpha-chain peptide
05/11/2000WO2000008651A3 Palladium coated implant
05/11/2000DE19910188A1 Implant, especially a stent, comprises a support at least partly covered with a layer of metal oxide and/or ceramic material to inhibit excessive cell growth
05/11/2000DE19855421A1 Implant, especially a stent, having surface cavities containing a radioactive material to inhibit excessive cell growth
05/11/2000CA2348536A1 Radiodense compositions
05/11/2000CA2347915A1 Enhanced radiation therapy
05/11/2000CA2346857A1 Implant with cavities containing therapeutic agents
05/10/2000EP0998946A1 Non-porphyrin compound for use as a diagnosticum and/or pharmaceutical
05/10/2000EP0998310A1 Coronary stent with a radioactive, radiopaque coating
05/10/2000EP0998309A1 Methods and systems for preparing and sealing radiation delivery structures
05/10/2000EP0998267A1 Internally supported lipid vesicle systems
05/09/2000US6060038 Radiolabeled farnesyl-protein transferase inhibitors
05/09/2000US6060037 Conjugated compounds which comprise an st receptor binding moiety and a radiostable active moiety
05/09/2000US6060036 Radioactive seed implants
05/04/2000WO2000024751A1 Chelating agents for radioimmunotherapy
05/04/2000WO2000004868A3 Libraries of polyhydroxamates and their analogs
05/04/2000WO1999063988A9 Inhibitors of nitric oxide synthase
05/04/2000WO1999061066A3 Convection-enhanced delivery of aav vectors
05/04/2000CA2346976A1 Chelating agents for radioimmunotherapy
05/03/2000EP0996619A1 Tropane analogs and methods for inhibition of monoamine transport
05/03/2000EP0996471A1 Radionuclide microparticles bound to elastomeric hose for the endovascular therapy
05/03/2000EP0996469A1 Methods of photoacoustic imaging
05/03/2000EP0776334A4 Stable analogs of bioactive peptides containing disulfide linkages
05/03/2000EP0625055B1 Use of fullerenes in diagnostic and/or therapeutic agents
05/03/2000EP0560947B1 Trivalent monospecific antigen binding proteins
05/02/2000US6057435 Nucleic acid coding for polypeptide which binds to receptor tyrosine kinase containing immunoglobulin-like and epidermal growth factor homology domains expressed in vascular endothelial cells; diagnosis/imaging; angiogenesis inhibition
05/02/2000US6057419 Drugs and images
05/02/2000US6057287 Kallikrein-binding "Kunitz domain" proteins and analogues thereof
05/02/2000US6057096 Photocleavable agents and conjugates for the detection and isolation of biomolecules
05/02/2000US6056973 Therapeutic liposome composition and method of preparation
05/02/2000US6056942 5-HT1A ligands
05/02/2000US6056941 Solution of boronic acid adducts of technetium-99 m dioxime complexes; and hydroxypropyl gamma cyclodextrin to maintain the solution free of particulate matter originating from the formulation.
05/02/2000US6056940 Technetium-99m complexing moiety covalently linked to a platelet glycoprotein iib/iiia receptor binding moiety having a molecular weight of less than 10,000 daltons
05/02/2000US6056939 Self-assembling heteropolymetallic chelates as imaging agents and radiopharmaceuticals
04/2000
04/27/2000WO2000023594A1 BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP)